Will King
Tara Homer
Professor Christopher Harding
Helen Mossop
Dr Thomas Chadwick
et al. | Cost-effectiveness of methenamine hippurate compared with antibiotic prophylaxis for the management of recurrent urinary tract infections in secondary care: a multicentre, open-label, randomised, non-inferiority trial | 2024 |
|
Dr Deborah Stocken
Helen Mossop
| Good Statistical Practice—development of tailored Good Clinical Practice training for statisticians | 2024 |
|
Professor Vijay Kunadian
Helen Mossop
Carol Shields
Philippa Watts
Professor Dawn Teare
et al. | Invasive Treatment Strategy for Older Patients with Myocardial Infarction | 2024 |
|
Helen Mossop
Dr Michael Grayling
Professor James Wason
| Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials | 2022 |
|
Professor Christopher Harding
Helen Mossop
Tara Homer
Dr Thomas Chadwick
Will King
et al. | Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial | 2022 |
|
Professor Christopher Harding
Dr Thomas Chadwick
Tara Homer
Jan Lecouturier
Helen Mossop
et al. | Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT | 2022 |
|
Professor Steve Robson
Catherine McParlin
Helen Mossop
Dr Mabel Lie
Dr Cristina Fernandez-Garcia
et al. | Ondansetron and metoclopramide as second-line antiemetics in women with nausea and vomiting in pregnancy: The empower pilot FACTORIAL RCT | 2021 |
|
Helen Mossop
| The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer – a study protocol | 2021 |
|
Dr Grant McGeechan
Denise Howel
Professor Eileen Kaner
Emerita Professor Elaine McColl
Professor Ruth McGovern
et al. | Brief alcohol intervention for risky drinking in young people aged 14 15 years in secondary schools: the SIPS JR-HIGH RCT | 2019 |
|
Dr Sophie Gu
Dr Ben Beska
Dr Danny Chan
Dr Jonathan Batty
Helen Mossop
et al. | Cognitive Decline in Older Patients With Non-ST Elevation Acute Coronary Syndrome | 2019 |
|
Dr Prosenjit Dutta
Dr Wendy Funston
Helen Mossop
Vicky Ryan
Rhys Jones
et al. | Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis | 2019 |
|
Dr Ben Beska
Dr Danny Chan
Helen Mossop
Professor Vijay Kunadian
| The association between Vitamin D status and clinical events in high-risk older patients with non-ST elevation acute coronary syndrome undergoing invasive management | 2019 |
|
Rebecca Forbes
Dr Alaa Abouhajar
Catherine Brennand
Dr Heather Brown
Dr Sonya Carnell
et al. | ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women (ALTAR): study protocol for a multicentre, pragmatic patient‐randomised non‐inferiority trial | 2018 |
|
Dr Antoneta Granic
Helen Mossop
Dr Karen Davies
Dr Richard Dodds
Professor Avan Sayer
et al. | Factors associated with physical performance measures in a multiethnic cohort of older adults | 2018 |
|
Helen Mossop
| Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial | 2016 |
|
Helen Mossop
| DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer | 2015 |
|
Helen Mossop
| Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial | 2015 |
|
